Results 131 to 140 of about 1,856,875 (191)

Transdiagnostic determinants of Growth Differentiation Factor-15 (GDF-15) in psychiatric in-patients: age, renal indices, interleukin-6 (IL-6) and soluble urokinase plasminogen activator receptor (suPAR). [PDF]

Brain Behav Immun Health
Tsapakis EM, Keskilidou E, Karapatis A, Kyziridis T, Prokopiou P, Karalazou P, Thisiadou A, Makedou K, Fountoulakis KN.   +8 more
europepmc   +1 more source

Maternal soluble urokinase plasminogen activator receptor levels in intrahepatic cholestasis of pregnancy: a predictor of neonatal intensive care unit admission. [PDF]

Rev Assoc Med Bras (1992)
Aktaş BA, Aktaş BA, Agaoglu Z, Peker BN, Başaran E, Orhan N, Özdal BB, Şahin D.   +7 more
europepmc   +1 more source

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Erectile Dysfunction in Diabetic Patients. [PDF]

J Clin Med
Erinc O, Yilmaz O, Kaya TY, Algemi M, Akarsu M.   +4 more
europepmc   +1 more source

Soluble Urokinase Plasminogen Activator Receptor Predicts Survival and Hepatic Decompensation in Advanced Hepatocellular Carcinoma. [PDF]

Liver Int
Artusa F, Lamatsch S, Phan MD, Özdirik B, Berger H, Egerer M, Knorr-Klocke J, Fischer J, Veelken R, van Bömmel F, Berg T, Kappert K, Tauber R, Puengel T, Engelmann C, Demir M, Tacke F, Mohr R.   +17 more
europepmc   +1 more source

The Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) as Predictive Tool in Hospitalised Patients With Community-Acquired Pneumonia (CAP). [PDF]

Clin Respir J
Hessels L, Duijkers R, Schoorl M, Terpstra L, Thijs W, Boersma W.   +5 more
europepmc   +1 more source

Soluble urokinase plasminogen activator receptor promotes endoplasmic reticulum stress and apoptosis susceptibility through RAGE in sepsis acute kidney injury. [PDF]

Mol Med
Wang B, Wang J, Qi C, Gao C, Wang Y, Zan Y, Tan Y, Wu Z, Jiang J, Suo J, Zhang J, Peng Z.   +11 more
europepmc   +1 more source

Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic biomarker in acutely admitted patients with atrial fibrillation. [PDF]

J Arrhythm
Wisborg FD, El Caidi NO, Taraldsen IA, Tonning S, Kandiah A, El-Sheikh M, Bahrami HSZ, Andersen O, Rasmussen LJH, Hove J, Dixen U, Grand J.   +11 more
europepmc   +1 more source

Association of soluble urokinase plasminogen activator receptor and epidermal growth factor with histopathological findings of kidney biopsy: a single-center study. [PDF]

BMC Nephrol
Nagy E, Almenshawy A, Abdelsalam M, Elwahab AMA, Gharbia OM, El-Husseiny Moustafa F, Ahmed NS, Khreba NA.   +7 more
europepmc   +1 more source

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Predicts 28-Day and 90-Day Mortality in Emergency Department Patients with Chest Pain, Dyspnoea, or Abdominal Pain. [PDF]

Diagnostics (Basel)
Gavelli F, Giolitti FM, Vidali M, Montersino M, Bertoli M, Molinari L, Baldrighi M, Beltrame M, Sainaghi PP, Bellan M, Patrucco F, Avanzi GC, Castello LM.   +12 more
europepmc   +1 more source

Soluble urokinase plasminogen activator receptor for risk stratification from undifferentiated acute chest pain through to convalescence after acute coronary syndromes. [PDF]

Eur Heart J Open
Keys T, Greer C, Adamson PD, Pickering JW, Pilbrow AP, Frampton C, Hayek S, Troughton RW, Doughty RN, Richards AM, Pemberton CJ, Chew-Harris J.   +11 more
europepmc   +1 more source